The novel virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused
a pandemic of coronavirus disease 2019 (COVID-19). Across the globe, a subset of patients …

Post-acute sequelae of COVID-19 (PASC) is emerging as global problem with unknown
molecular drivers. Using a digital epidemiology approach, we recruited 8,077 individuals to …

INTRODUCTION Although post facto studies have revealed the importance of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission from presymptomatic …

Considerable research has been done in investigating SARS‐CoV‐2 infection, its
characteristics, and host immune response. However, debate is still ongoing over the …

Objectives Symptom persistence weeks after laboratory-confirmed severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) clearance is a relatively common long-term …

Background: It is important to document the performance of rapid antigen tests (Ag-RDTs) in
detecting SARS-CoV-2 variants. Objective: To compare the performance of Ag-RDTs in …

Several millions of individuals are estimated to develop post-acute sequelae SARS-CoV-2
condition (PASC) that persists for months after infection. Here we evaluate the immune …

Importance Clinical data are lacking regarding the risk of viral transmission from individuals
who have positive reverse-transcription–polymerase chain reaction (RT-PCR) SARS-CoV-2 …

Background Severe clinical pictures and sequelae of COVID‐19 disease are immune
mediated and characterized by a 'cytokine storm'. Skeletal muscle has emerged as a potent …

We report the clinical characteristics and management of fourteen neonates and very young
infants with COVID-19. Although all presented with mild symptoms and did not require …